User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

1356

Interactions with Platform & by Email *

INTERACTIONS

244

Unique # Participated *

PARTICIPANTS

54

Responses Validated *

VALIDATIONS

14

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
Implantable Cardioverter Defibrillators (ICD).....I-3
  
   Pacemaker.....I-4
External Defibrillators.....I-4
Electrophysiology (EP) Catheterization, Mapping, and Ablation (CMA).....I-4
  
   A Prelude.....II-5
Cardiac Rhythm Management Devices - An Outlook.....II-5
Implantable Cardioverter Defibrillators.....II-5
1$100
   Pacemakers.....II-6
External Defibrillators.....II-6
EP Catheterization, Mapping, & Ablation (CMA).....II-6
Market Structure.....II-6
1$100
   Table 1: World Market for Cardiac Rhythm Management (CRM) Devices (2010): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart).....II-7

Table 2: World Market for High Power CRM Devices (2010): Percentage Breakdown of Annual Revenues by Companies. (includes corresponding Graph/Chart).....II-7

Table 3: World Market for Low Power CRM Devices (2010): Percentage Breakdown of Annual Revenues by Companies(includes corresponding Graph/Chart).....II-7
1$350
   Table 4: World Market for ImplanTable Cardioverter Defibrillator (2010): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart).....II-8

Table 5: World External Defibrillators Market (2010): Percentage Market Share Breakdown of Leading Players - Medtronic, Philips and Others (includes corresponding Graph/Chart) (includes corresponding Graph/Chart).....II-8

Table 6: World Market for Advanced Cardiac Resynchronization Therapy (CRT) Devices (2010): Percentage Market Share Breakdown of Leading Players - Medtronic, Boston Scientific (Guidant), St. Jude Medical, and Others (includes corresponding Graph/Chart).....II-8
1$350
   SSS and AV Block Incidence Triggers Demand for Pacemakers .....II-9
Infamous Product Recalls Throw Growth Off-track.....II-9
Market Shapes Up After the Recall Shock.....II-9
1$100
   Regulatory Riders Knit to Ensure Greater Device Reliability.....II-10
Growing Proportion of Obese Population: A Major Demographic Driver.....II-10
Replacements to Drive the Growth of ICDs.....II-10
1$100
   Developments in Energy-Based Therapies Augur Well for Cardiac Ablation
  Treatments.....II-11
Expanding Applications Lend Traction to Growth.....II-11
1$100
   Prices of Cardiac Pacemakers Soften.....II-12
Heart Patients Using ICD, Enjoy Satisfactory Quality Life.....II-12
Pacemakers Ensure Effective Management of Non-Systolic Heart Failures.....II-12
1$100
   CRT: An Effective Treatment for Bradycardia, Tachycardia & Fibrillation.....II-13
ICDs in Pediatric Care Shows Promise.....II-13
Emerging Therapies for the Treatment of Atrial Fibrillation.....II-13
1$100
   New Generation CRM Devices Feature Superior Benefits.....II-14
MRI-Compatible Pacemakers & ICDs.....II-14
1$100
   Resistance Against Electronic Interferences.....II-15
Confusion Over the Use of CRM Devices Threaten Perceived Effectiveness.....II-15
1$100
   Breathing Disorders in Patients Implanted with Pacemakers: A Cause for Concern.....II-16
Approval of Untested Pacemaker Connectors Raises Eyebrows.....II-16
1$100
   ICD Lead Failure Demands Immediate Attention.....II-17
Pacemaker Hacking Has the Industry Up by Its Ears.....II-17
Pacemakers Face Stiff Competition from CRT-D Devices.....II-17
1$100
   ICDs More Prone to Malfunction than Pacemakers.....II-18
Conclusion.....II-18
Technology Innovation: A Futuristic Rumination.....II-18
The Heart to Power CRM Devices: The Future of CRM Therapies.....II-18
1$100
   Genetic Advances to Yield Replacement for Pacemakers.....II-19
Ablation Technology Undergoing Innovations.....II-19
Vein Ablation Catheter Proves Successful in Cases of Paroxysmal Atrial
  Fibrillation.....II-19
1$100
   Ablation Therapy Useful in Treating Persistent/ Permanent Atrial Fibrillation
  (PPAF).....II-20
Magnetic Navigation: An Innovation in Catheter Ablation.....II-20
New Force-Sensing Ablation Catheter Aims to Aid Physician Decision Making.....II-20
1$100
   Pricing & Reimbursements: Critical Determinants of Growth.....II-21
New Guidelines Issued for Safe Management of CRM Devices in the US and Europe.....II-21
2$125
   Sudden Cardiac Arrest: A Leading Cause of Death.....II-23
Cardiac Rhythm Management (CRM): A Definition.....II-23
Implantable Cardioverter Defibrillators (ICDs).....II-23
1$100
   Surgical Implantation of ICDs: The Procedure.....II-24
ICDs – The Benefits.....II-24
Types of ICDs.....II-24
1$100
   ICDs: An Evolution Scan.....II-25
Complications Associated With ICD Usage.....II-25
CRT-D – A New Therapeutic Device.....II-25
Pacemakers.....II-25
1$100
   Surgical Implantation of Pacemakers: The Procedure.....II-26
Types of Pacemakers.....II-26
Methods of Pacing.....II-26
Fixed Rate Pacemakers.....II-26
1$100
   Demand Pacemakers.....II-27
Rate-Responsive Pacemaker.....II-27
Pacemakers: An Evolution Scan.....II-27
Complications Associated with Pacemakers.....II-27
1$100
   Advent of CRT-P.....II-28
Electrophysiology (EP) Catheterization, Mapping, and Ablation (CMA).....II-28
The Ablation Procedure.....II-28
1$100
   External Defibrillators.....II-29
Types of AEDs.....II-29
1$100
   Cardiac Rhythm Disorders: A Brief Review.....II-30
Cardiac Arrhythmias.....II-30
Classification of Cardiac Arrhythmias.....II-30
1$100
   Bradycardia.....II-31
Tachycardia.....II-31
Atrial Fibrillation.....II-31
1$100
   Heart Blocks.....II-32
Syncope.....II-32
Sick Sinus Syndrome.....II-32
1$100
   Cardiomyopathy.....II-331$100
   Boston Scientific Unveils CRM Connector System.....II-34
Biosense Catheter Receives FDA Marketing Approval.....II-34
St. Jude Medical Secures Approval for Atlas II ICD from Japan.....II-34
Zoll Medical Defibrillators Receive FDA Clearance.....II-34
1$100
   St. Jude Medical Receives CE Mark for Integrated Irrigation Pump and Ablation
  Generator.....II-35
AtriCure Secures FDA 510(k) Approval for Coolrail Device.....II-35
Hansen Medical Gains FDA Approval for CoHesion™ Module.....II-35
1$100
   St. Jude Medical Obtains CE Mark and FDA Approval for HIFU Surgical Ablation
  Solutions.....II-36
Biosense Releases NAVISTAR® RMT THERMOCOOL® Catheter.....II-36
1$100
   Atricure Unveils The ORLab™.....II-37
Cardima Receives SFDA Approval to Market INTELLITEMP® in China.....II-37
ZOLL Obtains 510K Clearance to Sell and Market Zoll R Series Code-Ready
  Defibrillator.....II-37
1$100
   ST. Jude Medical Obtains FDA and CE Mark Approval for New Epicor LP Cardiac Ablation
  System.....II-38
Cardima Obtains Approval for Marketing Surgical Ablation System in Thailand.....II-38
ATS Medical Introduces First CryoMaze Surgical Ablation Clamp.....II-38
CardioNet Unveils New Reporting Package for Atrial Fibrillation Treatment.....II-38
1$100
   Boston Scientific Defibrillator Receives CE Mark Approval.....II-39
TyRx Introduces New Anti-bacterial Envelope, AIGISRX™ ICD.....II-39
St. Jude Medical Receives Approval from Japanese MHLW.....II-39
1$100
   Boston Scientific Secures FDA Approval for CRM Solutions.....II-40
Sorin Group Develops New-Generation CRT-D Implants.....II-40
BSC Secures CE Mark Approval for ALTRUA Pacemakers.....II-40
1$100
   Medtronic Secures FDA Approval for New Vision 3D Devices.....II-41
Medtronic Obtains FDA Approval for Software Update.....II-41
St. Jude Medical Obtains FDA Approval for SJM Cardiac Monitor.....II-41
1$100
   Boston Scientific Obtains Approval For Cognis CRT-D And Teligen ICD.....II-42
FDA Approves Medtronic’s Medtronic Sprint Quattro Secure® S Lead.....II-42
Medtronic Obtains CE Mark Approval for Pacemaker and Pacing Leads.....II-42
St. Jude Medical Obtains Japanese Approval for Victory® Pacemakers Family.....II-42
1$100
   Sorin Group Obtains Approval For Isoline Defibrillation Leads In Japan.....II-43
BSC Secures FDA Approval for New ALTRUA Pacemakers.....II-43
1$100
   St. Jude Medical Obtains Approval for Durata Defibrillation Lead.....II-44
St. Jude Medical Obtains Japanese Approval for Durata Defibrillation Lead.....II-44
St. Jude Medical Obtains Japanese Approval for Victory Family of Pacemakers.....II-44
1$100
   Sorin Group Gains FDA Approval for OVATIO™.....II-45
Sorin SpA Gains FDA Approval for REPLY.....II-45
Medtronic Receives Approval for Lead Integrity Alert™.....II-45
Physio-Control Gains FDA Approval for LIFEPAK® 20e Defibrillator/Monitor.....II-45
1$100
   TyRx Introduces New Anti-Bacterial Envelope, AIGISRX™ ICD.....II-46
LifeWatch Introduces Next-Generation Monitor, LifeStar ACT III Platinum.....II-46
eCardio Launches eVolution, New Cardiac Monitoring System.....II-46
1$100
   Philips Introduces PageWriter TC70 Cardiograph.....II-47
Sorin Group Announces Commercial Release and First Implant of PARADYM™ CRT
  8750.....II-47
St. Jude Medical Introduces QuickOpt® Timing Cycle Optimization in CRT-D.....II-47
1$100
   Cardiac Science Unveils Simple Electronic Reporting System.....II-48
Mennen Medical Introduces VitaLogik® 4000 Line.....II-48
1$100
   BIOTRONIK Releases CRT-P in US Market.....II-49
Vermed Releases Defibrillation Pads Series and Universal Connector System.....II-49
St. Jude Releases Reflexion Spiral X™ in US.....II-49
1$100
   Novation Partners St. Jude Medical for CRM Products.....II-50
Medtronic Sets Up Production Unit in Singapore.....II-50
Novation Collaborates with BIOTRONIK.....II-50
Boston Scientific Inks Agreement with Fukuda Denshi.....II-50
1$100
   Creganna Closes Tactx Medical Acquisition.....II-51
Medtronic Takes Over Ablation Frontiers.....II-51
Sorin Enters into Agreement with Orange Business Services.....II-51
1$100
   Philips Signs a Deal with Bard Electrophysiology.....II-52
Boston Scientific Bags CRM Contract from Dept. of Veterans Affairs.....II-52
Medtronic and Boston Scientific Inks Agreement to End IP Disputes.....II-52
1$100
   St Jude Medical to Invest in Penang.....II-53
Cardima Enters into a Distribution Agreement with Peerless Medical.....II-53
Cardiac Science Enters into an Alliance with Boy Scouts of America.....II-53
1$100
   Cardima Enters into a New Strategic Surgical Alliance with Biocore.....II-54
Cardima Enters into a New Strategic Marketing Alliance with On-X Life
  Technologies.....II-54
Welch Allyn and ZOLL Medical Corporation Collaborate.....II-54
1$100
   Cardima Selects Dot Medical to Distribute Its EP Products in the UK.....II-55
Royal Philips to Guide ‘euHeart’ Project.....II-55
Target Center Acquires HeartSine® Defibrillators.....II-55
1$100
   St Jude Medical Acquires EP MedSystems.....II-56
St. Jude Takes Over Radi Medical AB.....II-56
Medrad to Acquire Possis.....II-56
Phoenix Acquires Stake in Possis.....II-56
1$100
   Biotronik Acquires VascoMed.....II-57
Medtronic Takes Over CryoCath Technologies.....II-57
Boston Scientific Takes Over CryoCor.....II-57
St. Jude Completes Acquisition of MediGuide.....II-57
1$100
   Greatbatch Enters Into A Strategic Partnership With Issys.....II-58
Sorin Group Inks Collaborative Agreement with Greatbatch.....II-58
Philips Enters into MOU with King’s College London on Research Collaboration.....II-58
1$100
   Welch Allyn Collaborates with ZOLL Medical Corporation.....II-59
ZOLL and HealthTrust Sign Purchasing Deal.....II-59
ZOLL Inks Multi-Year Agreement with Masimo.....II-59
First Responder Wins Contract from Harvard School of Public Health.....II-59
1$100
   Beijing Airport Group to Deploy ZOLL AED Plus Solutions.....II-60
STH NHS Trust to Deploy New R Series BLS Solutions of ZOLL.....II-60
Major EMS Centers in China Deploys ZOLL M Series Defibrillator.....II-60
1$100
   DRF to Deploy corpuls3 Heart Defibrillators.....II-61
Riedel & Schulz and GS Elektromed Distributes 8 corpuls3 Medical Units.....II-61
Trivitron Inks Marketing And Distribution Agreement With Boston Scientific.....II-61
CardioComm Signs Licensing Agreement with GE Healthcare.....II-61
Cambridge Heart Licenses Technology for Implantable Devices.....II-61
1$100
   Synovis Life Technologies to Divest Interventional Business.....II-62
Boston Scientific Divests Cardiac Surgery And Vascular Surgery Businesses.....II-62
Sorin Group Sells Its Vascular Therapy Business to CIDl.....II-62
1$100
   Bard Electrophysiology (US).....II-63
Biosense Webster, Inc. (US).....II-63
Biotronik GMBH & Co. KG (Germany).....II-63
Boston Scientific Corporation (US).....II-63
1$100
   Medtronic, Inc. (US).....II-64
Medtronic CryoCath LP (US).....II-64
Vitatron Nederland BV (Netherlands).....II-64
1$100
   Philips Healthcare (The Netherlands).....II-65
St. Jude Medical, Inc. (US).....II-65
Sorin Group (Italy).....II-65
1$100
   Table 7: World Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Geographic Region - US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-661$350
   Table 8: World Historic Review for Cardiac Rhythm Management Devices by Geographic Region - US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-671$350
   Table 9: World 15-Year Perspective for Cardiac Rhythm Management Devices by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-681$350
   Table 10: World Recent Past, Current & Future Analysis for ImplanTable Cardioverter Defibrillators by Geographic Region - US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-691$350
   Table 11: World Historic Review for Implantable Cardioverter Defibrillators by Geographic Region - US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-701$350
   Table 12: World 15-Year Perspective for ImplanTable Cardioverter Defibrillators by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-711$350
   Table 13: World Recent Past, Current & Future Analysis for Pacemakers by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-721$350
   Table 14: World Historic Review for Pacemakers by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-731$350
   Table 15: World 15-Year Perspective for Pacemakers by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-741$350
   Table 16: World Recent Past, Current & Future Analysis for External Defibrillators by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-751$350
   Table 17: World Historic Review for External Defibrillators by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-761$350
   Table 18: World 15-Year Perspective for External Defibrillators by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-771$350
   Table 19: World Recent Past, Current & Future Analysis for EP Catheterization, Mapping, & Ablation (CMA) by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-781$350
   Table 20: World Historic Review for EP Catheterization, Mapping, & Ablation (CMA) by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-791$350
   Table 21: World 15-Year Perspective for EP Catheterization, Mapping, & Ablation (CMA) by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-801$350
   A. Market Analysis.....II-81
Outlook.....II-81
Market Overview.....II-81
Demand for Automated External Defibrillators Shoots Up in the US.....II-81
1$100
   Market Share Statistics.....II-82
Table 22: US Market for (ICD) Implantable Cardioverter Defibrillators (2011): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart).....II-82

Table 23: US Market for Core Pacemakers & CRT-P (2010): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart).....II-82
Cardiovascular Disease Incidence Statistics.....II-82
Table 24: Cardiovascular Diseases in US (2010): Percentage Breakdown of Total Economic Cost Incurred for Treatment by Disease Type (includes corresponding Graph/Chart).....II-82
1$350
   Table 25: Cardiovascular Diseases in US (2010): Percentage Breakdown of Total Economic Cost Incurred for Treatment by Type of Expenditure (includes corresponding Graph/Chart).....II-83

Table 26: Cardiovascular Diseases (CvD) in US (2010): Incidence of CvDs in Adult Population Segregated by Age and Gender (includes corresponding Graph/Chart).....II-83
1$350
   Table 27: Cardiovascular Diseases (CvD) in the US (2010): Percentage Breakdown of Deaths by Type of Causal CvD (includes corresponding Graph/Chart).....II-841$350
   B. Market Analytics.....II-85
Table 28: US Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-85
1$350
   Table 29: US Historic Review for Cardiac Rhythm Management Devices by Product Segment - ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-861$350
   Table 30: US 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment – Percentage Breakdown of Dollar Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-871$350
   A. Market Analysis.....II-88
Outlook.....II-88
Major Market Trends.....II-88
Flourishing Market for CRM Market in Western Europe.....II-88
Bright Future for CRM Devices Industry.....II-88
1$100
   Highly Competitive External Defibrillators Market Paves Way for
  Consolidations.....II-89
Strong Demand for Implantable Cardiac Defibrillators in UK.....II-89
1$100
   B. Market Analytics.....II-90
Table 31: European Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-90
1$350
   Table 32: European Historic Review for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-911$350
   Table 33: European 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment – Percentage Breakdown of Dollar Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-921$350
   A. Market Analysis.....II-93
Outlook.....II-93
Major Market Trends.....II-93
Increasing Heart Diseases Spur Demand for CRM Devices.....II-93
Chinese CRM Market to Witness Robust Growth.....II-93
1$100
   B. Market Analytics.....II-94
Table 34: Asia Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-94
1$350
   Table 35: Asia Pacific Historic Review for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-951$350
   Table 36: Asia Pacific 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment – Percentage Breakdown of Dollar Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-961$350
   A. Market Analysis.....II-97
Outlook.....II-97
Market Share Statistics.....II-97
Table 37: ImplanTable Cardioverter Defibrillator (ICD) Market in EMEA, Asia, & South America (2010): Percentage Market Share Breakdown of Leading Players – Medtronic, Boston Scientific (Guidant), St Jude Medical, and Others (includes corresponding Graph/Chart).....II-97

Table 38: Core Pacemakers & CRT-P Market in EMEA, Asia, & South America (2010): Percentage Market Share Breakdown of Leading Players – Medtronic, St. Jude, Boston Scientific and Others (includes corresponding Graph/Chart).....II-97
1$350
   B. Market Analytics.....II-98
Table 39: Rest of World Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-98
1$350
   Table 40: Rest of World Historic Review for Cardiac Rhythm Management Devices by Product Segment – ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-991$350
   Table 41: Rest of World 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment – Percentage Breakdown of Dollar Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-1001$350
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com